Cargando…
Infliximab Therapy Leading to Pulmonary Tuberculosis in a Patient With Negative Interferon γ Release Assay (IGRA)-Based QuantiFERON Gold Test
Infliximab therapy is associated with higher rates of active tuberculosis (TB), particularly extrapulmonary and disseminated forms with unusual symptoms. We report the case of a 66-year-old man with Crohn’s disease who developed TB mimicking lung cancer on imaging. He presented with cough and fever...
Autores principales: | Parita, Soni, Vivek, Kumar, Stephan, Kamholz, William, Pascal, Yizhak, Kupfer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507378/ https://www.ncbi.nlm.nih.gov/pubmed/28748193 http://dx.doi.org/10.1177/2324709617717540 |
Ejemplares similares
-
Unusual Interferon Gamma Measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube Tests
por: Powell, Richard D., et al.
Publicado: (2011) -
Comparison of LIAISON QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold Plus
por: Kadkhoda, Kamran, et al.
Publicado: (2023) -
Serial Assays of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in Subjects Exposed to Patients with Active Tuberculosis
por: Moon, Hee-Won, et al.
Publicado: (2020) -
QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-tube assays for
detecting latent tuberculosis infection in Thai healthcare
workers
por: Rudeeaneksin, Janisara, et al.
Publicado: (2023) -
QuantiFERON-TB Gold PLUS versus QuantiFERON-TB Gold In-Tube test for diagnosing tuberculosis infection
por: Kim, Soo Han, et al.
Publicado: (2020)